Skip to main content
Addgene
Showing: 381 - 400 of 941 results

  1. pAAV-CaMKIIa-hM3D(Gq)-mCherry (AAV8)

    Viral Prep
    #50476-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-CaMKIIa-hM3D(Gq)-mCherry (#50476). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hM3D(Gq)-mCherry plasmid DNA. CaMKIIa-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    CaMKII
    Tags
    mCherry
    Available since
    Oct. 26, 2016
    Availability
    Academic Institutions and Nonprofits only

  2. AAV-CamKIIa-jGCaMP8s-WPRE (AAV1)

    Viral Prep
    #176752-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AAV-CamKIIa-jGCaMP8s-WPRE (#176752). In addition to the viral particles, you will also receive purified AAV-CamKIIa-jGCaMP8s-WPRE plasmid DNA. CamKIIa-driven expression of calcium sensor GCaMP8s (more sensitive). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Loren Looger
    Promoter
    CamKIIalpha
    Tags
    None
    Available since
    July 12, 2023
    Availability
    Academic Institutions and Nonprofits only

  3. AAV phSyn1(S)-tdTomato-WPRE (AAV5)

    Viral Prep
    #51506-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from AAV phSyn1(S)-tdTomato-WPRE (#51506). In addition to the viral particles, you will also receive purified AAV phSyn1(S)-tdTomato-WPRE plasmid DNA. hSyn-driven tdTomato expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Hongkui Zeng
    Article
    Oh et al Nature. 2014 Apr 10;508(7495):207-14. do
    Promoter
    phSyn1
    Tags
    tdTomato
    Available since
    Nov. 29, 2021
    Availability
    Academic Institutions and Nonprofits only

  4. pAAV-EF1a-fDIO-Cre (AAV9)

    Viral Prep
    #121675-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Alexander Nectow, Esteban Engel
    Article
    Schneeberger et al Cell. 2019 Jun 24. pii: S0092-8674(19)30
    Promoter
    EF1a
    Tags
    None
    Available since
    June 4, 2019
    Availability
    Academic Institutions and Nonprofits only

  5. pAAV-EF1a-fDIO-Cre (AAV1)

    Viral Prep
    #121675-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Alexander Nectow, Esteban Engel
    Article
    Schneeberger et al Cell. 2019 Jun 24. pii: S0092-8674(19)30
    Promoter
    EF1a
    Tags
    None
    Available since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only

  6. pAAV-hSyn-EGFP (AAV1 trial size)

    Viral Prep
    #50465-AAV1.T
    Purpose
    Ready-to-use AAV1 trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    Syn
    Tags
    EGFP
    Available since
    July 12, 2019
    Availability
    Academic Institutions and Nonprofits only

  7. pAAV-CAG-GFP (AAV1 trial size)

    Viral Prep
    #37825-AAV1.T
    Purpose
    Ready-to-use AAV1 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Promoter
    CAG
    Tags
    GFP
    Available since
    May 29, 2019
    Availability
    Academic Institutions and Nonprofits only

  8. pAAV-Ef1a-fDIO-JRGECO1a (AAV1)

    Viral Prep
    #128317-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-Ef1a-fDIO-JRGECO1a (#128317). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO-JRGECO1a plasmid DNA. EF1a-driven, Flp-dependent expression of the biosensor jRGECO1a. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Patricia Jensen
    Promoter
    EF1a
    Tags
    None
    Available since
    March 18, 2024
    Availability
    Academic Institutions and Nonprofits only

  9. pAAV-nEF-NpHR3.3-EYFP (AAV8)

    Viral Prep
    #137151-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-nEF-NpHR3.3-EYFP (#137151). In addition to the viral particles, you will also receive purified pAAV-nEF-NpHR3.3-EYFP plasmid DNA. nEF-driven expression of NpHR3.3-EYFP for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    INTRSECT 2.0 Project, Karl Deisseroth
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    nEF
    Tags
    EYFP
    Available since
    May 5, 2021
    Availability
    Academic Institutions and Nonprofits only

  10. pAAV-S5E2-C1V1-eYFP (AAV9)

    Viral Prep
    #135633-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-S5E2-C1V1-eYFP (#135633). In addition to the viral particles, you will also receive purified pAAV-S5E2-C1V1-eYFP plasmid DNA. Expression of red-shifted opsin C1V1 fused to EYFP under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Jordane Dimidschstein
    Article
    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.
    Promoter
    Tags
    EYFP
    Available since
    Aug. 27, 2021
    Availability
    Academic Institutions and Nonprofits only

  11. pAAV-Ef1a-fDIO mCherry (AAV1)

    Viral Prep
    #114471-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-Ef1a-fDIO mCherry (#114471). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO mCherry plasmid DNA. Ef1a-driven, Flp recombinase-dependent expression of mCherry. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Promoter
    EF1a
    Tags
    mCherry (Flp-dependent)
    Available since
    Dec. 3, 2019
    Availability
    Academic Institutions and Nonprofits only

  12. pAAV-CaMKIIa-hM4D(Gi)-mCherry (AAV2)

    Viral Prep
    #50477-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CaMKIIa-hM4D(Gi)-mCherry (#50477). In addition to the viral particles, you will also receive purified pAAV-CaMKIIa-hM4D(Gi)-mCherry plasmid DNA. CaMKIIa-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal silencing. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Bryan Roth
    Promoter
    CaMKII
    Tags
    mCherry
    Available since
    March 12, 2021
    Availability
    Academic Institutions and Nonprofits only

  13. AAV-hSyn-Soma-jGCaMP8m (AAV9)

    Viral Prep
    #169257-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from AAV-hSyn-Soma-jGCaMP8m (#169257). In addition to the viral particles, you will also receive purified AAV-hSyn-Soma-jGCaMP8m plasmid DNA. Syn-driven expression of soma-targeted calcium sensor jGCaMP8m. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Marianne Fyhn
    Article
    Grodem et al Nat Commun. 2023 Feb 4;14(1):608. doi: 1
    Promoter
    Tags
    None
    Available since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only

  14. pAAV-TREtight-mTagBFP2-B19G (AAV1)

    Viral Prep
    #100799-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-TREtight-mTagBFP2-B19G (#100799). In addition to the viral particles, you will also receive purified pAAV-TREtight-mTagBFP2-B19G plasmid DNA. Helper virus for monosynaptic tracing with rabies virus; to be coinjected with pAAV-syn-FLEX-splitTVA-EGFP-tTA (Addgene# 100798). These AAV preparations are suitable purity for injection into animals.
    Depositor
    Ian Wickersham
    Article
    Liu et al Nature. 2017 Aug 31;548(7669):582-587. d
    Promoter
    TREtight
    Tags
    BFP (in presence of Cre and 100798)
    Available since
    Dec. 18, 2018
    Availability
    Academic Institutions and Nonprofits only

  15. pAAV-mDlx-NLS-mRuby2 (AAV1)

    Viral Prep
    #99130-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-mDlx-NLS-mRuby2 (#99130). In addition to the viral particles, you will also receive purified pAAV-mDlx-NLS-mRuby2 plasmid DNA. mDlx-driven NLS-mRuby2 expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Viviana Gradinaru
    Article
    Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.
    Promoter
    mDLX5/6
    Tags
    mRuby2
    Available since
    Jan. 14, 2019
    Availability
    Academic Institutions and Nonprofits only

  16. AAV-EF1a-jGCaMP8m-WPRE (AAV1)

    Viral Prep
    #176757-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AAV-EF1a-jGCaMP8m-WPRE (#176757). In addition to the viral particles, you will also receive purified AAV-EF1a-jGCaMP8m-WPRE plasmid DNA. EF1a-driven expression of calcium sensor GCaMP8m. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Loren Looger
    Promoter
    EF1a
    Tags
    None
    Available since
    July 12, 2023
    Availability
    Academic Institutions and Nonprofits only

  17. pAAV-hsyn-flex-Voltron-ST (AAV1)

    Viral Prep
    #119036-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hsyn-flex-Voltron-ST (#119036). In addition to the viral particles, you will also receive purified pAAV-hsyn-flex-Voltron-ST plasmid DNA. Synapsin-driven, cre-dependent expression of genetically encoded fluorescent voltage indicator Voltron1 with a soma-targeting sequence. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Eric Schreiter
    Article
    Abdelfattah et al Science. 2019 Aug 1. pii: science.aav641
    Promoter
    Syn
    Tags
    None
    Available since
    April 10, 2019
    Availability
    Academic Institutions and Nonprofits only

  18. pAAV-nEF-ChRmine-mScarlet (AAV8)

    Viral Prep
    #137158-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV-nEF-ChRmine-mScarlet (#137158). In addition to the viral particles, you will also receive purified pAAV-nEF-ChRmine-mScarlet plasmid DNA. nEF-driven expression of ChRmine-mScarlet. These AAV preparations are suitable purity for injection into animals.
    Depositor
    INTRSECT 2.0 Project, Karl Deisseroth
    Article
    Fenno et al Neuron. 2020 Jun 20. pii: S0896-6273(20)
    Promoter
    nEF
    Tags
    mScarlet
    Available since
    April 8, 2021
    Availability
    Academic Institutions and Nonprofits only

  19. pAAV-Ef1a-fDIO mCherry (AAV2)

    Viral Prep
    #114471-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-Ef1a-fDIO mCherry (#114471). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO mCherry plasmid DNA. Ef1a-driven, Flp recombinase-dependent expression of mCherry. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Karl Deisseroth
    Promoter
    EF1a
    Tags
    mCherry (Flp-dependent)
    Available since
    March 31, 2020
    Availability
    Academic Institutions and Nonprofits only

  20. pAAV-CAG-GFP (AAV5 trial size)

    Viral Prep
    #37825-AAV5.T
    Purpose
    Ready-to-use AAV5 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Edward Boyden
    Promoter
    CAG
    Tags
    GFP
    Available since
    May 29, 2019
    Availability
    Academic Institutions and Nonprofits only
Showing: 381 - 400 of 941 results